Aprea Therapeutics Statistics
Total Valuation
APRE has a market cap or net worth of $6.31 million. The enterprise value is -$31.54 million.
| Market Cap | 6.31M |
| Enterprise Value | -31.54M |
Important Dates
The last earnings date was Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
APRE has 14.19 million shares outstanding. The number of shares has increased by 432.43% in one year.
| Current Share Class | 12.59M |
| Shares Outstanding | 14.19M |
| Shares Change (YoY) | +432.43% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 7.96% |
| Owned by Institutions (%) | 10.18% |
| Float | 7.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,890.31 |
| Forward PS | n/a |
| PB Ratio | 0.18 |
| P/TBV Ratio | 0.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.67, with zero debt.
| Current Ratio | 9.67 |
| Quick Ratio | 9.52 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -60.87% and return on invested capital (ROIC) is -41.09%.
| Return on Equity (ROE) | -60.87% |
| Return on Assets (ROA) | -35.95% |
| Return on Invested Capital (ROIC) | -41.09% |
| Return on Capital Employed (ROCE) | -43.86% |
| Weighted Average Cost of Capital (WACC) | 13.55% |
| Revenue Per Employee | $417 |
| Profits Per Employee | -$1.77M |
| Employee Count | 8 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.00% in the last 52 weeks. The beta is 1.69, so APRE's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | -65.00% |
| 50-Day Moving Average | 0.64 |
| 200-Day Moving Average | 0.74 |
| Relative Strength Index (RSI) | 34.63 |
| Average Volume (20 Days) | 152,094 |
Short Selling Information
The latest short interest is 525,159, so 3.70% of the outstanding shares have been sold short.
| Short Interest | 525,159 |
| Short Previous Month | 621,151 |
| Short % of Shares Out | 3.70% |
| Short % of Float | 6.64% |
| Short Ratio (days to cover) | 2.56 |
Income Statement
In the last 12 months, APRE had revenue of $3,337 and -$14.14 million in losses. Loss per share was -$0.44.
| Revenue | 3,337 |
| Gross Profit | -8.42M |
| Operating Income | -15.28M |
| Pretax Income | -14.14M |
| Net Income | -14.14M |
| EBITDA | -15.26M |
| EBIT | -15.28M |
| Loss Per Share | -$0.44 |
Balance Sheet
The company has $37.85 million in cash and no debt, with a net cash position of $37.85 million or $2.67 per share.
| Cash & Cash Equivalents | 37.85M |
| Total Debt | n/a |
| Net Cash | 37.85M |
| Net Cash Per Share | $2.67 |
| Equity (Book Value) | 34.84M |
| Book Value Per Share | 2.40 |
| Working Capital | 34.46M |
Cash Flow
In the last 12 months, operating cash flow was -$12.72 million and capital expenditures -$15,401, giving a free cash flow of -$12.74 million.
| Operating Cash Flow | -12.72M |
| Capital Expenditures | -15,401 |
| Depreciation & Amortization | 22,508 |
| Net Borrowing | n/a |
| Free Cash Flow | -12.74M |
| FCF Per Share | -$0.90 |
Margins
| Gross Margin | n/a |
| Operating Margin | -457,872.76% |
| Pretax Margin | -423,878.66% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
APRE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -432.43% |
| Shareholder Yield | -432.43% |
| Earnings Yield | -97.93% |
| FCF Yield | -201.96% |
Analyst Forecast
The average price target for APRE is $3.30, which is 642.41% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.30 |
| Price Target Difference | 642.41% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on February 13, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Feb 13, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
APRE has an Altman Z-Score of -11.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -11.46 |
| Piotroski F-Score | 2 |